FDA Inspection 1294476 — Zhejiang Hisoar Chuannan Pharmaceutical Co. Ltd.
The FDA completed an inspection of Zhejiang Hisoar Chuannan Pharmaceutical Co. Ltd. on October 31, 2025 in Taizhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 31, 2025
- Fiscal Year
- 2026
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Taizhou (China)